Advanced interatrial block predicts recurrence of atrial fibrillation after accessory pathway ablation in patients with Wolff‐Parkinson‐White syndrome

por Wu, Jin‐Tao, Zhao, Dan‐Qing, Li, Fei‐Fei, Wu, Rui, Fan, Xian‐Wei, Hu, Guang‐Ling, Bai, Min‐Fu, Yang, Hai‐Tao, Yan, Li‐Jie, Liu, Jing‐Jing, Xu, Xian‐Jing, Wang, Shan‐Ling, Chu, Ying‐Jie
Publicado 2019

Effect of pulmonary vein isolation on atrial fibrillation recurrence after accessory pathway ablation in patients with Wolff‐Parkinson‐White syndrome

por Wu, Jin‐Tao, Zhao, Dan‐Qing, Li, Fei‐Fei, Zhang, Lei‐Ming, Hu, Juan, Fan, Xian‐Wei, Hu, Guang‐Ling, Yang, Hai‐Tao, Yan, Li‐Jie, Liu, Jing‐Jing, Xu, Xian‐Jing, Wang, Shan‐Ling, Chu, Ying‐Jie
Publicado 2020

PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation

por Hu, Juan, Zhang, Jing‐Jing, Li, Li, Wang, Shan‐Ling, Yang, Hai‐Tao, Fan, Xian‐Wei, Zhang, Lei‐Ming, Hu, Guang‐Ling, Fu, Hai‐Xia, Song, Wei‐Feng, Yan, Li‐Jie, Liu, Jing‐Jing, Wu, Jin‐Tao, Kong, Bin
Publicado 2021